Odyssey Health (ODYY) Convertible Debt (2025)
Odyssey Health (ODYY) reported Convertible Debt of $1.7 million for Q4 2025, up 4.8% sequentially from $1.6 million in Q3 2025.
Odyssey Health (ODYY) Convertible Debt (2025) Analysis & Trends
Odyssey Health has disclosed Convertible Debt across 1 years of filings, most recently posting $1.7 million for Q4 2025.
- Quarterly Convertible Debt changed N/A year-over-year to $1.7 million in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $1.7 million (changed N/A YoY) and the FY2025 annual result came in at $1.6 million, changed N/A from the prior year.
- Convertible Debt climbed to $1.7 million in Q4 2025, from $1.6 million in the prior quarter.
- Across five years, Convertible Debt topped out at $1.7 million in Q4 2025 and bottomed at $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 1.66 Mn |
| Jul 31, 2025 | 1.58 Mn |